{"id":"https://openalex.org/W2010655738","doi":"https://doi.org/10.1111/j.1365-2141.2009.07917.x","title":"Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group","display_name":"Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group","publication_year":2009,"publication_date":"2009-10-05","ids":{"openalex":"https://openalex.org/W2010655738","doi":"https://doi.org/10.1111/j.1365-2141.2009.07917.x","mag":"2010655738","pmid":"https://pubmed.ncbi.nlm.nih.gov/19804455","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2809127"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2009.07917.x","doi":"https://doi.org/10.1111/j.1365-2141.2009.07917.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2009.07917.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2809127","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark R. Litzow","raw_affiliation_strings":["Mayo Clinic, Rochester, MN 55905, USA. litzow.mark@mayo.edu","Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN 55905, USA. litzow.mark@mayo.edu","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028772063","display_name":"Megan K. D. Othus","orcid":"https://orcid.org/0000-0001-8176-6371","observed_orcids":["https://orcid.org/0000-0001-8176-6371"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Othus","raw_affiliation_strings":["Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016061346","display_name":"Larry Dean Cripe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larry D. Cripe","raw_affiliation_strings":["University of Indiana, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Indiana, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101760493","display_name":"Steven D. Gore","orcid":"https://orcid.org/0000-0002-3649-8758","observed_orcids":["https://orcid.org/0000-0002-3649-8758"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven D. Gore","raw_affiliation_strings":["Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042915360","display_name":"Hillard Michael Lazarus","orcid":"https://orcid.org/0000-0002-1159-5607","observed_orcids":["https://orcid.org/0000-0002-1159-5607"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hillard M. Lazarus","raw_affiliation_strings":["University Hospitals Case Medical Center, Ireland Cancer Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Case Medical Center, Ireland Cancer Center, Cleveland, OH","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I4210119077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051157099","display_name":"Sandra J. Lee","orcid":"https://orcid.org/0000-0002-8626-639X","observed_orcids":["https://orcid.org/0000-0002-8626-639X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra J. Lee","raw_affiliation_strings":["Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065804627","display_name":"John M. Bennett","orcid":"https://orcid.org/0000-0001-7517-5567","observed_orcids":["https://orcid.org/0000-0001-7517-5567"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Bennett","raw_affiliation_strings":["University of Rochester Cancer Center, University of Rochester, Rochester, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Rochester Cancer Center, University of Rochester, Rochester, NY","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079511754","display_name":"Elisabeth M. Paietta","orcid":"https://orcid.org/0000-0002-0561-5544","observed_orcids":["https://orcid.org/0000-0002-0561-5544"]},"institutions":[{"id":"https://openalex.org/I4210119873","display_name":"Lady of Mercy Medical Center","ror":"https://ror.org/02navrb60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626","https://openalex.org/I4210119873"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabeth M. Paietta","raw_affiliation_strings":["Our Lady of Mercy Cancer Center, Bronx, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Our Lady of Mercy Cancer Center, Bronx, NY","institution_ids":["https://openalex.org/I4210119873"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113542194","display_name":"Gordon W. Dewald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon W. Dewald","raw_affiliation_strings":["Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101869658","display_name":"Jacob M. Rowe","orcid":"https://orcid.org/0000-0002-2016-2918","observed_orcids":["https://orcid.org/0000-0002-2016-2918"]},"institutions":[{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Jacob M. Rowe","raw_affiliation_strings":["Department of Hematology and BMT, Rambam Medical Center, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and BMT, Rambam Medical Center, Haifa, Israel","institution_ids":["https://openalex.org/I2801301638"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001124933","display_name":"Martin S. Tallman","orcid":"https://orcid.org/0000-0002-4367-6102","observed_orcids":["https://orcid.org/0000-0002-4367-6102"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin S. Tallman","raw_affiliation_strings":["Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5085360755"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":4.6875,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.9506071,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"148","issue":"2","first_page":"217","last_page":"225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemtuzumab-ozogamicin","display_name":"gemtuzumab ozogamicin","score":0.9160000085830688},{"id":"https://openalex.org/keywords/liposomal-daunorubicin","display_name":"liposomal daunorubicin","score":0.9620000123977661},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.753000020980835},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8930000066757202},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.421999990940094},{"id":"https://openalex.org/keywords/high-risk-relapse","display_name":"high-risk relapse","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8856306076049805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7081764936447144},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.6944888830184937},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.660677969455719},{"id":"https://openalex.org/C2778623314","wikidata":"https://www.wikidata.org/wiki/Q412685","display_name":"Gemtuzumab ozogamicin","level":5,"score":0.5737481117248535},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5152730941772461},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.46496230363845825},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.443853497505188},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4180278778076172},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3946239650249481},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33705073595046997},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.06423872709274292},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000079982","descriptor_name":"Gemtuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1365-2141.2009.07917.x","doi":"https://doi.org/10.1111/j.1365-2141.2009.07917.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2009.07917.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:19804455","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19804455","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:europepmc.org:1948513","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2809127","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2809127","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2809127","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Br J Haematol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:1948513","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2809127","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1011812605","display_name":null,"funder_award_id":"CA-49883","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1257575315","display_name":null,"funder_award_id":"CA-11083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1270243726","display_name":"Eastern Cooperative Oncology Group","funder_award_id":"U10CA049883","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1363485433","display_name":"ECOG Statistical Office Data Management Grant","funder_award_id":"U10CA066636","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1422427855","display_name":null,"funder_award_id":"CA-23318","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2017411191","display_name":null,"funder_award_id":"CA17145","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2087378654","display_name":"EASTERN COOPERATIVE ONCOLOGY GROUP","funder_award_id":"U10CA014958","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G286468852","display_name":null,"funder_award_id":"CA13650","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3704097003","display_name":"Eastern Cooperative Oncology Group","funder_award_id":"U10CA016116","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G407604337","display_name":"ECOG Clinical Trials","funder_award_id":"U10CA017145","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4412485521","display_name":null,"funder_award_id":"CA66636","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4478607185","display_name":"Southwest Oncology Group","funder_award_id":"U10CA011083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5066121848","display_name":"Eastern Cooperative Oncology Group Studies","funder_award_id":"U10CA014548","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5765316850","display_name":null,"funder_award_id":"CA-16116","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G631691829","display_name":null,"funder_award_id":"CA14548","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6796618889","display_name":"Eastern Cooperative Oncology Group","funder_award_id":"U10CA013650","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7473345701","display_name":"ECOG Specimen Banking","funder_award_id":"U24CA114737","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8112161023","display_name":"ECOG Statistical Office","funder_award_id":"U10CA023318","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8181418271","display_name":"Eastern Cooperative Oncology Group Operations Office","funder_award_id":"U10CA021115","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G92717670","display_name":null,"funder_award_id":"CA14958","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G964706321","display_name":null,"funder_award_id":"CA 21115","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W71772178","https://openalex.org/W183128447","https://openalex.org/W305459207","https://openalex.org/W1492609361","https://openalex.org/W1498501198","https://openalex.org/W1534965621","https://openalex.org/W1814791463","https://openalex.org/W1842764967","https://openalex.org/W1964060298","https://openalex.org/W1971100415","https://openalex.org/W1974926775","https://openalex.org/W1979300931","https://openalex.org/W1981920314","https://openalex.org/W1988676466","https://openalex.org/W1993385847","https://openalex.org/W1996034543","https://openalex.org/W2006055464","https://openalex.org/W2006420057","https://openalex.org/W2008610145","https://openalex.org/W2023561451","https://openalex.org/W2032149555","https://openalex.org/W2036479586","https://openalex.org/W2042853163","https://openalex.org/W2043216151","https://openalex.org/W2061960126","https://openalex.org/W2065406906","https://openalex.org/W2092582176","https://openalex.org/W2094681262","https://openalex.org/W2104359420","https://openalex.org/W2119941477","https://openalex.org/W2134193067","https://openalex.org/W2145240921","https://openalex.org/W2147083172","https://openalex.org/W2159507916","https://openalex.org/W2162920526","https://openalex.org/W2174523573","https://openalex.org/W2190800131","https://openalex.org/W2410674130","https://openalex.org/W2411119170","https://openalex.org/W2537595153","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W1983994230","https://openalex.org/W2808444974","https://openalex.org/W2361861296","https://openalex.org/W2039795723","https://openalex.org/W7204195873","https://openalex.org/W2159746057","https://openalex.org/W2899512090","https://openalex.org/W2048312112","https://openalex.org/W2573122082","https://openalex.org/W3130804482"],"abstract_inverted_index":{"The":[0,87,114],"treatment":[1,184],"of":[2,78,90,95,112,147,160,164,175,185],"relapsed":[3,143,187],"acute":[4],"myeloid":[5],"leukaemia":[6],"(AML)":[7],"remains":[8],"unsatisfactory.":[9],"We":[10,171],"conducted":[11],"a":[12,72,76,82,96,102],"phase":[13],"II":[14],"randomized":[15],"trial":[16,92,196],"where":[17],"patients":[18,67,121,140,161],"received":[19],"intermediate-dose":[20],"cytarabine":[21,45],"for":[22,39,47,53,61,117],"4":[23],"d":[24,41,49,55,63],"followed":[25],"by":[26,58],"gemtuzumab":[27],"ozogamicin":[28],"on":[29],"day":[30],"5":[31,48,62],"(Arm":[32,42,64],"A),":[33],"or":[34,44,81,84,101,150,188],"combined":[35,50],"with":[36,51],"liposomal":[37],"daunorubicin":[38],"3":[40,54],"B),":[43],"given":[46],"cyclophosphamide":[52],"and":[56,133],"topotecan":[57],"continuous":[59],"infusion":[60],"C).":[65],"Eligible":[66],"had":[68,142,152],"primary":[69,88],"refractory":[70,189],"AML,":[71],"first":[73],"relapse":[74],"after":[75],"remission":[77,99],"<1":[79],"year,":[80],"second":[83],"greater":[85],"relapse.":[86],"objective":[89],"this":[91],"was":[93,197],"attainment":[94],"conventional":[97],"complete":[98],"(CR)":[100],"CR":[103,149],"without":[104],"platelet":[105],"recovery":[106],"(CRp)":[107],"in":[108,125,130,136,182],"at":[109,199],"least":[110],"40%":[111],"patients.":[113],"CR/CRp":[115],"rates":[116],"the":[118,183],"82":[119],"eligible":[120],"were":[122,169,179],"3/26":[123],"(12%)":[124],"Arm":[126,131,137],"A,":[127],"2/29":[128],"(7%)":[129],"B,":[132],"1/27":[134],"(4%)":[135],"C.":[138],"No":[139,166],"who":[141,151],"within":[144],"6":[145],"months":[146],"initial":[148],"suffered":[153],"multiple":[154],"relapses":[155],"responded.":[156],"More":[157],"than":[158],"95%":[159],"subsequently":[162],"died":[163],"AML.":[165],"unexpected":[167],"toxicities":[168],"encountered.":[170],"conclude":[172],"that":[173],"none":[174],"these":[176],"three":[177],"regimens":[178],"effective":[180],"enough":[181],"high-risk":[186],"AML":[190],"to":[191],"warrant":[192],"further":[193],"study.":[194],"This":[195],"registered":[198],"http://www.clinicaltrials.gov":[200],"as":[201],"#NCT00005962.":[202]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}